Bristol-Myers Squibb Company
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2022
Total Assets: $96.82B
Liabilities Breakdown FY2022
Total Liabilities: $65.70B
Asset Breakdown
Total Assets: $96.82B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $9.12B | 9.4% |
| Accounts Receivable | $8.15B | 8.4% |
| Inventory | $2.34B | 2.4% |
| Property, Plant & Equipment | $6.26B | 6.5% |
| Goodwill | $21.15B | 21.8% |
| Intangible Assets | $35.86B | 37.0% |
| Other Assets | $13.94B | 14.4% |
Liabilities Breakdown
Total Liabilities: $65.70B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.04B | 4.6% |
| Long-Term Debt | $35.06B | 53.4% |
| Other Liabilities | $27.61B | 42.0% |